Developed data sharing and acquisition strategies as well as marketing and partnering materials

Developed, sold, and launched first pilot projects with pharmaceutical clients, leading to company’s first revenue

Conducted and oversaw contract development to establish data sharing procedures

Left due to pivot into healthcare IT, I have a personal interest to remain closer to biotech / drug development.

Managed case teams of 3-5 direct reports to advise small biotechs through Big Pharma clients in creating business development and pipeline prioritization strategies, managing M&A diligence processes, constructing valuation and partnership models, and synthesizing market forecasts

Broad exposure to the life science sectors and markets particularly in gene therapy, rare diseases, and oncology

Constructed model to quantify impacts of IPO lockup expiration and clinical milestones

Translated findings into actionable recommendations for current positions

Conducted strategic analysis of gene therapy market conditions for investment diligence

Led development of novel purification technique for the varicella vaccine
•$150MM/batch estimated cost savings upon implementation in current manufacturing
•Drove capital acquisitions totaling 25% of the departmental budget

Led for development of an automated nuclei assay
•Significantly reduced assay operating time by 80% and method variability by 85%
•Improved process monitoring of manufacturing processes

Project manager for Development / Supply team - supported 2 product launches